Cancer Related Funding Opportunities

Department of Defence Funding Opportunities

07/01/2021 to 10/07/2021 - Dept of Defense - Pancreatic Cancer Research Program (PCARP)

Applications submitted to the FY21 PCARP must address one or more of the following Focus Areas:

  • Early detection research for pancreatic cancer, including studies of individuals with pre-diabetes and diabetes and/or those in underserved ethnic and minority communities
  • Supportive care and patient-reported outcomes, quality of life, and perspectives during treatment and survivorship
  • Understanding the relationship between metabolic disruptions in pancreatic cancer and their systemic effects, including diabetes and cachexia
  • Understanding precursors, origins, and early progression of pancreatic cancer
  • Understanding the events that promote pancreatic cancer metastasis
  • Understanding the relationship between oncogenic signaling and the tumor microenvironment that drives drug resistance and therapeutic response
  • New drug development targeted toward cancer sensitivity and resistance mechanisms including immune mechanisms of resistance

Idea Development Award (IDA)
Pre-Application (Preproposal): July 1, 2021
Application: October 7, 2021

Translational Research Partnership Award (TRPA)
Pre-Application (Preproposal): July 1, 2021
Application: October 7, 2021

More Information

07/13/2021 to 10/15/2021 - Dept of Defense - Rare Cancers Research Program

Vision Statement
To greatly improve outcomes for people with rare cancer through discovery and community building, and expansion of knowledge across the cancer landscape.

Mission Statement
Elevate rare cancers research to enable clinically impactful discoveries for the benefit of Service Members, their families, Veterans, and the American public.

Concept Award and Idea Development Award applications submitted to the FY21 RCRP must address one or more of the following Focus Areas:

  • Biology and Etiology: Identify disease-defining molecular pathways, cell context, and microenvironment.
  • Research Model: Develop and validate rare tumor-specific models that can support clinical trial readiness.
  • Therapy: Identify novel therapeutic strategies, including drug repurposing.

Pre-Application (Preproposal): July 13, 2021

Application: October 15, 2021

Resource and Community Development Award applications submitted to the FY21 RCRP must address the Focus Areas below:

  • Platform Development: Development of platforms (such as tumor tissue repository with clinical annotation, centralized databanks, patient registry with common data structure, research model and Omics database, longitudinal studies of natural history, and treatment response) for multiple rare cancers, to allow sharing of data, bio-specimens, and resources.

Pre-Application (Preproposal): July 13, 2021

Application: October 15, 2021

More Information

09-08-2021 to 09/27/2021 - Dept of Defense - Breast Cancer Research Program

Applications submitted to the FY21 BCRP must address one or more of the following overarching challenges:

  • Prevent breast cancer (primary prevention)
  • Identify determinants of breast cancer initiation, risk, or susceptibility
  • Distinguish deadly from non-deadly breast cancers
  • Conquer the problems of overdiagnosis and overtreatment
  • Identify what drives breast cancer growth; determine how to stop it
  • Identify why some breast cancers become metastatic
  • Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence
  • Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival
  • Eliminate the mortality associated with metastatic breast cancer

Breakthrough Award Levels 1 and 2 II (BTA12)
Pre-Application (Letter of Intent): September 8, 2021
Application: September 22, 2021

Era of Hope Scholar Award II (EOHSA2)
Pre-Application (Letter of Intent): September 8, 2021
Application: September 22, 2021
Confidential Letters of Recommendation Submission Deadline: September 27, 2021

More Information

09/09/2021 to 11/10/2021 - Dept of Defense - Melanoma Research Program (MRP)

Applications submitted to the FY21 MRP must address one or more of the following focus areas:

  • Identify methods to decrease risk of melanoma development beyond sunscreen and protective clothing
  • Identify and understand risk factor determinants for melanoma, including variants (e.g., uveal, acral, mucosal melanoma)
  • Identify how the tumor microenvironment (e.g., stromal, immune, microbiome) impact tumor initiation, response to therapy, progression, and dormancy
  • Understand how precursor lesions and endogenous host factors may lead to melanomagenesis
  • Develop new decision-making tools for the detection and diagnosis of melanoma that include easily accessible technology (beyond the dermoscope) for primary care physicians and dermatologists
  • Develop prediction and surveillance tools for distinguishing patient at risk for recurrence and/or metastasis. Identify biological determinants to differentiate patient populations
  • Understand mechanisms that underlie metastatic spread to different (regional/nodal) sites or the different distant sites of metastasis from acral, mucosal, and uveal melanomas
  • Delineate the molecular pathways, tumor microenvironment, immune response that influence metastatic spread, recurrence, and/or dormancy

Discovery Award (DA)
Pre-Application (Letter of Intent): October 20, 2021
Application: November 10, 2021

Mid-Career Accelerator Award (MCAA) 
Pre-Application (Letter of Intent): September 9, 2021
Application: September 28, 2021

Team Science Award (TSA)
Pre-Application (Letter of Intent): September 9, 2021
Application: September 28, 2021

Translational Research Award (TRA)
Pre-Application (Letter of Intent): September 9, 2021
Application: September 28, 2021

More Information

September 2021 Application Deadlines

09/06/2021 - Concern Foundation: Conquer Cancer Now Award

The Concern Foundation focuses its funding in the areas of immunology, immunotherapy, genetics, and cell biology. Its Conquer Cancer Now Award program awards grants of $60,000 a year for up to two years to young cancer researchers in support of hypothesis-driven research centered on cancer genetics, cancer biology, or cancer immunology. The foundation does not fund clinical trials, cancer epidemiology, or behavioral studies.

Amount/Duration: $60,000 a year for up to two years

Eligibility: Applicants must be an independent investigator at the start of his/her scientific career (i.e., junior faculty) and at the level of assistant professor (or equivalent, with explanation). Successful proposals are usually from investigators who have been in their independent position and directing their own research program for more than a year. Applications are accepted from institutions in the United States and abroad and U.S. citizenship is not a requirement.

Application Deadline: September 6, 2021

More Information

09/23/2021 - American Lung Association - Lung Cancer Discovery Award

The objective of the Lung Cancer Discovery Award is to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods.

Amount/Duration: $100,000 per year for up to two years

Eligibility: At the time of application, candidates must be United States citizens or foreign nationals holding one of the following visa immigration statuses: permanent resident (Green Card), exchange visitor (J-1), temporary Page | 2 worker in a specialty occupation (H-1B), Canadian or Mexican citizen engaging in professional activities (TN), Australians in Specialty Occupation (E-3) or temporary worker with extraordinary abilities in the sciences (O-1). At the time of application and throughout the award, an applicant must be employed by a U.S. institution.

LOI Deadline: September 23, 2021

More Information

October 2021 Application Deadlines

10/01/2021 - CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity

CRI recognizes that getting to the next great breakthroughs in cancer immunotherapy requires a diverse and inclusive community of researchers. These fellowships support qualified young scientists from underrepresented minorities at leading universities and research centers around the world who wish to receive training in fundamental immunology and cancer immunology. The program provides additional support for mentoring and career advancement to these individuals.

CRI invites applications from candidates who identify as Black or African American, Hispanic or Latino/a American, or American Indian or Alaska Native.

CRI is seeking hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer.

Application Deadlines: October 1, 2021

More Information

10/06/2021 to 01/19/2022 - Rising Tide Foundation and Melanoma Research Alliance First in Human Trials Funding Opportunity

In early August 2021, MRA will issue its annual RFP; and as with past years, a 2nd release will be issued in early September. Within the second release, Rising Tide Foundation and MRA plan to include a special opportunity to fund up to two awards to advance new treatment approaches to first in human melanoma patient trials. Funding is anticipated to support up to $1.5 million for each of the two awards, over a five-year period. Critical to these opportunities will be a patient-centric approach, where patients are engaged early on, and throughout the project in designing/refining/and guiding of such research efforts to ensure patient needs and preferences are front and center.

Key Deadlines:

  • October 6: Team Science Award Letters of Intent Due
  • November 3: Young Investigator Award Eligibility Checklist Due to rfischer@curemelanoma.org.
  • November 17: Young Investigator and Pilot Awards Full Proposals Due
  • January 19: Team Science Award Full Proposals Due (from invited applicants)

More Information

10/16/2021 to 06/16/2023 - National Cancer Institute/NIH/DHHS - Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in the U.S. Specifically, this FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.

Application Deadlines: 16-Oct-2021 , 16-Feb-2022 , 16-Jun-2022 , 16-Oct-2022 , 16-Feb-2023 , 16-Jun-2023

More Information

GCO Funding Opportunities

Monthly and continuous submission funding opportunity packets are available on the GCO Funding Opportunities web page.

STAY CONNECTED

Sign up for the Research Listserv to stay up to date with the latest news and events.